Drugs / Urotensin II
Urotensin II
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00654966 | Jun 2009 → Dec 2010 | heart failure | Monash University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Urotensin II | “Urotensin II (U-II) is newly discovered protein that may play an important role in human health and disease.” NCT00654966 ↗ |
| Known as | U-II | “Urotensin II (U-II) is newly discovered protein that may play an important role in human health and disease.” NCT00654966 ↗ |
| Known as | Urotensine II | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00654966 ↗ |
| Modality | Protein / enzyme biologic | “Urotensin II (U-II) is newly discovered protein that may play an important role in human health and disease.” NCT00654966 ↗ |
| Route | Other | “A few drops of the drug will be administered to the skin by iontophoresis.” NCT00654966 ↗ |